Related Experiment Videos
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells
M E Steffey1, G L Snyder, R W Barrett
1Abbott Laboratories, Neuroscience Research Division, Pharmaceutical Discovery, Abbott Park, IL 60064.
Abstract:
Dopamine is shown to stimulate cAMP accumulation in COS-1 cells via endogenously expressed dopamine D1 receptors. A dissociation of dopamine and beta-adrenoceptor responses is demonstrated by the use of selective antagonists and different desensitization patterns following exposure of the cells to dopamine or the beta-adrenoceptor agonist, isoproterenol. The dopamine response in COS-1 cells exhibits a pharmacological profile similar to that found in dopamine D1 tissues such as rat striatum and fish retina. The presence of DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, Mr 32,000) immunoreactivity in COS-1 cells is shown by Western blotting and is consistent with the endogenous expression of a dopamine D1 receptor in these cells. It is concluded that a dopamine D1 receptor is expressed in COS-1 cells and the implications of this are discussed.
Insights
COS-1 cells express dopamine D1 receptors, responding to dopamine by increasing cAMP. This response is distinct from beta-adrenoceptor activity, suggesting specific dopamine D1 receptor signaling in these cells.
Area of Science:
- Neuropharmacology
- Cellular Biology
- Molecular Signaling
Background:
- Dopamine receptors are crucial for neurotransmission.
- Dopamine D1 receptors mediate various cellular responses, including cAMP accumulation.
- Understanding dopamine receptor expression in non-neuronal cells can reveal novel signaling pathways.
Purpose of the Study:
- To investigate the presence and function of dopamine receptors in COS-1 cells.
- To characterize the signaling pathway activated by dopamine in COS-1 cells.
- To compare the pharmacological profile of dopamine response in COS-1 cells with known dopamine D1 receptor tissues.
Main Methods:
- Stimulation of COS-1 cells with dopamine and isoproterenol.
- Use of selective antagonists to differentiate receptor responses.
- Analysis of cAMP accumulation as a downstream signaling event.
- Western blotting to detect DARPP-32 immunoreactivity.
Main Results:
- Dopamine stimulates cAMP accumulation in COS-1 cells.
- The dopamine response is distinct from beta-adrenoceptor stimulation.
- Pharmacological profiling aligns with endogenous dopamine D1 receptors.
- DARPP-32 immunoreactivity confirms dopamine D1 receptor presence.
Conclusions:
- COS-1 cells endogenously express functional dopamine D1 receptors.
- This finding has implications for studying dopamine signaling in a cellular model.
- The characterized response provides insights into dopamine D1 receptor pharmacology.